Global Intramuscular Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Description

The global Intramuscular Vaccine Adjuvants market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Intramuscular Vaccine Adjuvants is used for Intramuscular injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.

This report studies the global Intramuscular Vaccine Adjuvants production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Intramuscular Vaccine Adjuvants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intramuscular Vaccine Adjuvants that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Intramuscular Vaccine Adjuvants total production and demand, 2019-2030, (K Units)
Global Intramuscular Vaccine Adjuvants total production value, 2019-2030, (USD Million)
Global Intramuscular Vaccine Adjuvants production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Intramuscular Vaccine Adjuvants consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Intramuscular Vaccine Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Intramuscular Vaccine Adjuvants production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Intramuscular Vaccine Adjuvants production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Intramuscular Vaccine Adjuvants production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Intramuscular Vaccine Adjuvants market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health and Associated British Foods, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intramuscular Vaccine Adjuvants market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Intramuscular Vaccine Adjuvants Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Intramuscular Vaccine Adjuvants Market, Segmentation by Type
    Infectious Diseases
    Cancer
    Others

Global Intramuscular Vaccine Adjuvants Market, Segmentation by Application
    Research Applications
    Commercial Applications

Companies Profiled:
    GSK
    Dynavax Technologies
    Novavax
    Agenus
    Croda International
    Seppic
    OZ Biosciences
    Phibro Animal Health
    Associated British Foods
    InvivoGen
    Merck KGaA
    CSL Limited

Key Questions Answered
1. How big is the global Intramuscular Vaccine Adjuvants market?
2. What is the demand of the global Intramuscular Vaccine Adjuvants market?
3. What is the year over year growth of the global Intramuscular Vaccine Adjuvants market?
4. What is the production and production value of the global Intramuscular Vaccine Adjuvants market?
5. Who are the key producers in the global Intramuscular Vaccine Adjuvants market?

Table of Contents

1 Supply Summary
    1.1 Intramuscular Vaccine Adjuvants Introduction
    1.2 World Intramuscular Vaccine Adjuvants Supply & Forecast
        1.2.1 World Intramuscular Vaccine Adjuvants Production Value (2019 & 2023 & 2030)
        1.2.2 World Intramuscular Vaccine Adjuvants Production (2019-2030)
        1.2.3 World Intramuscular Vaccine Adjuvants Pricing Trends (2019-2030)
    1.3 World Intramuscular Vaccine Adjuvants Production by Region (Based on Production Site)
        1.3.1 World Intramuscular Vaccine Adjuvants Production Value by Region (2019-2030)
        1.3.2 World Intramuscular Vaccine Adjuvants Production by Region (2019-2030)
        1.3.3 World Intramuscular Vaccine Adjuvants Average Price by Region (2019-2030)
        1.3.4 North America Intramuscular Vaccine Adjuvants Production (2019-2030)
        1.3.5 Europe Intramuscular Vaccine Adjuvants Production (2019-2030)
        1.3.6 China Intramuscular Vaccine Adjuvants Production (2019-2030)
        1.3.7 Japan Intramuscular Vaccine Adjuvants Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Intramuscular Vaccine Adjuvants Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Intramuscular Vaccine Adjuvants Major Market Trends

2 Demand Summary
    2.1 World Intramuscular Vaccine Adjuvants Demand (2019-2030)
    2.2 World Intramuscular Vaccine Adjuvants Consumption by Region
        2.2.1 World Intramuscular Vaccine Adjuvants Consumption by Region (2019-2024)
        2.2.2 World Intramuscular Vaccine Adjuvants Consumption Forecast by Region (2025-2030)
    2.3 United States Intramuscular Vaccine Adjuvants Consumption (2019-2030)
    2.4 China Intramuscular Vaccine Adjuvants Consumption (2019-2030)
    2.5 Europe Intramuscular Vaccine Adjuvants Consumption (2019-2030)
    2.6 Japan Intramuscular Vaccine Adjuvants Consumption (2019-2030)
    2.7 South Korea Intramuscular Vaccine Adjuvants Consumption (2019-2030)
    2.8 ASEAN Intramuscular Vaccine Adjuvants Consumption (2019-2030)
    2.9 India Intramuscular Vaccine Adjuvants Consumption (2019-2030)

3 World Intramuscular Vaccine Adjuvants Manufacturers Competitive Analysis
    3.1 World Intramuscular Vaccine Adjuvants Production Value by Manufacturer (2019-2024)
    3.2 World Intramuscular Vaccine Adjuvants Production by Manufacturer (2019-2024)
    3.3 World Intramuscular Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Intramuscular Vaccine Adjuvants Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Intramuscular Vaccine Adjuvants Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Intramuscular Vaccine Adjuvants in 2023
        3.5.3 Global Concentration Ratios (CR8) for Intramuscular Vaccine Adjuvants in 2023
    3.6 Intramuscular Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.6.1 Intramuscular Vaccine Adjuvants Market: Region Footprint
        3.6.2 Intramuscular Vaccine Adjuvants Market: Company Product Type Footprint
        3.6.3 Intramuscular Vaccine Adjuvants Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Intramuscular Vaccine Adjuvants Production Value Comparison
        4.1.1 United States VS China: Intramuscular Vaccine Adjuvants Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Intramuscular Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Intramuscular Vaccine Adjuvants Production Comparison
        4.2.1 United States VS China: Intramuscular Vaccine Adjuvants Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Intramuscular Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Intramuscular Vaccine Adjuvants Consumption Comparison
        4.3.1 United States VS China: Intramuscular Vaccine Adjuvants Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Intramuscular Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Intramuscular Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Intramuscular Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Intramuscular Vaccine Adjuvants Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Intramuscular Vaccine Adjuvants Production (2019-2024)
    4.5 China Based Intramuscular Vaccine Adjuvants Manufacturers and Market Share
        4.5.1 China Based Intramuscular Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Intramuscular Vaccine Adjuvants Production Value (2019-2024)
        4.5.3 China Based Manufacturers Intramuscular Vaccine Adjuvants Production (2019-2024)
    4.6 Rest of World Based Intramuscular Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Intramuscular Vaccine Adjuvants Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production (2019-2024)

5 Market Analysis by Type
    5.1 World Intramuscular Vaccine Adjuvants Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Infectious Diseases
        5.2.2 Cancer
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Intramuscular Vaccine Adjuvants Production by Type (2019-2030)
        5.3.2 World Intramuscular Vaccine Adjuvants Production Value by Type (2019-2030)
        5.3.3 World Intramuscular Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Intramuscular Vaccine Adjuvants Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Research Applications
        6.2.2 Commercial Applications
    6.3 Market Segment by Application
        6.3.1 World Intramuscular Vaccine Adjuvants Production by Application (2019-2030)
        6.3.2 World Intramuscular Vaccine Adjuvants Production Value by Application (2019-2030)
        6.3.3 World Intramuscular Vaccine Adjuvants Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Intramuscular Vaccine Adjuvants Product and Services
        7.1.4 GSK Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 Dynavax Technologies
        7.2.1 Dynavax Technologies Details
        7.2.2 Dynavax Technologies Major Business
        7.2.3 Dynavax Technologies Intramuscular Vaccine Adjuvants Product and Services
        7.2.4 Dynavax Technologies Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Dynavax Technologies Recent Developments/Updates
        7.2.6 Dynavax Technologies Competitive Strengths & Weaknesses
    7.3 Novavax
        7.3.1 Novavax Details
        7.3.2 Novavax Major Business
        7.3.3 Novavax Intramuscular Vaccine Adjuvants Product and Services
        7.3.4 Novavax Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Novavax Recent Developments/Updates
        7.3.6 Novavax Competitive Strengths & Weaknesses
    7.4 Agenus
        7.4.1 Agenus Details
        7.4.2 Agenus Major Business
        7.4.3 Agenus Intramuscular Vaccine Adjuvants Product and Services
        7.4.4 Agenus Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Agenus Recent Developments/Updates
        7.4.6 Agenus Competitive Strengths & Weaknesses
    7.5 Croda International
        7.5.1 Croda International Details
        7.5.2 Croda International Major Business
        7.5.3 Croda International Intramuscular Vaccine Adjuvants Product and Services
        7.5.4 Croda International Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Croda International Recent Developments/Updates
        7.5.6 Croda International Competitive Strengths & Weaknesses
    7.6 Seppic
        7.6.1 Seppic Details
        7.6.2 Seppic Major Business
        7.6.3 Seppic Intramuscular Vaccine Adjuvants Product and Services
        7.6.4 Seppic Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Seppic Recent Developments/Updates
        7.6.6 Seppic Competitive Strengths & Weaknesses
    7.7 OZ Biosciences
        7.7.1 OZ Biosciences Details
        7.7.2 OZ Biosciences Major Business
        7.7.3 OZ Biosciences Intramuscular Vaccine Adjuvants Product and Services
        7.7.4 OZ Biosciences Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 OZ Biosciences Recent Developments/Updates
        7.7.6 OZ Biosciences Competitive Strengths & Weaknesses
    7.8 Phibro Animal Health
        7.8.1 Phibro Animal Health Details
        7.8.2 Phibro Animal Health Major Business
        7.8.3 Phibro Animal Health Intramuscular Vaccine Adjuvants Product and Services
        7.8.4 Phibro Animal Health Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Phibro Animal Health Recent Developments/Updates
        7.8.6 Phibro Animal Health Competitive Strengths & Weaknesses
    7.9 Associated British Foods
        7.9.1 Associated British Foods Details
        7.9.2 Associated British Foods Major Business
        7.9.3 Associated British Foods Intramuscular Vaccine Adjuvants Product and Services
        7.9.4 Associated British Foods Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Associated British Foods Recent Developments/Updates
        7.9.6 Associated British Foods Competitive Strengths & Weaknesses
    7.10 InvivoGen
        7.10.1 InvivoGen Details
        7.10.2 InvivoGen Major Business
        7.10.3 InvivoGen Intramuscular Vaccine Adjuvants Product and Services
        7.10.4 InvivoGen Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 InvivoGen Recent Developments/Updates
        7.10.6 InvivoGen Competitive Strengths & Weaknesses
    7.11 Merck KGaA
        7.11.1 Merck KGaA Details
        7.11.2 Merck KGaA Major Business
        7.11.3 Merck KGaA Intramuscular Vaccine Adjuvants Product and Services
        7.11.4 Merck KGaA Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Merck KGaA Recent Developments/Updates
        7.11.6 Merck KGaA Competitive Strengths & Weaknesses
    7.12 CSL Limited
        7.12.1 CSL Limited Details
        7.12.2 CSL Limited Major Business
        7.12.3 CSL Limited Intramuscular Vaccine Adjuvants Product and Services
        7.12.4 CSL Limited Intramuscular Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 CSL Limited Recent Developments/Updates
        7.12.6 CSL Limited Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Intramuscular Vaccine Adjuvants Industry Chain
    8.2 Intramuscular Vaccine Adjuvants Upstream Analysis
        8.2.1 Intramuscular Vaccine Adjuvants Core Raw Materials
        8.2.2 Main Manufacturers of Intramuscular Vaccine Adjuvants Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Intramuscular Vaccine Adjuvants Production Mode
    8.6 Intramuscular Vaccine Adjuvants Procurement Model
    8.7 Intramuscular Vaccine Adjuvants Industry Sales Model and Sales Channels
        8.7.1 Intramuscular Vaccine Adjuvants Sales Model
        8.7.2 Intramuscular Vaccine Adjuvants Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Intramuscular Vaccine Adjuvants Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Intramuscular Vaccine Adjuvants Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Intramuscular Vaccine Adjuvants Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Intramuscular Vaccine Adjuvants Production Value Market Share by Region (2019-2024)
    Table 5. World Intramuscular Vaccine Adjuvants Production Value Market Share by Region (2025-2030)
    Table 6. World Intramuscular Vaccine Adjuvants Production by Region (2019-2024) & (K Units)
    Table 7. World Intramuscular Vaccine Adjuvants Production by Region (2025-2030) & (K Units)
    Table 8. World Intramuscular Vaccine Adjuvants Production Market Share by Region (2019-2024)
    Table 9. World Intramuscular Vaccine Adjuvants Production Market Share by Region (2025-2030)
    Table 10. World Intramuscular Vaccine Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Intramuscular Vaccine Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Intramuscular Vaccine Adjuvants Major Market Trends
    Table 13. World Intramuscular Vaccine Adjuvants Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Intramuscular Vaccine Adjuvants Consumption by Region (2019-2024) & (K Units)
    Table 15. World Intramuscular Vaccine Adjuvants Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Intramuscular Vaccine Adjuvants Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Intramuscular Vaccine Adjuvants Producers in 2023
    Table 18. World Intramuscular Vaccine Adjuvants Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Intramuscular Vaccine Adjuvants Producers in 2023
    Table 20. World Intramuscular Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Intramuscular Vaccine Adjuvants Company Evaluation Quadrant
    Table 22. World Intramuscular Vaccine Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Intramuscular Vaccine Adjuvants Production Site of Key Manufacturer
    Table 24. Intramuscular Vaccine Adjuvants Market: Company Product Type Footprint
    Table 25. Intramuscular Vaccine Adjuvants Market: Company Product Application Footprint
    Table 26. Intramuscular Vaccine Adjuvants Competitive Factors
    Table 27. Intramuscular Vaccine Adjuvants New Entrant and Capacity Expansion Plans
    Table 28. Intramuscular Vaccine Adjuvants Mergers & Acquisitions Activity
    Table 29. United States VS China Intramuscular Vaccine Adjuvants Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Intramuscular Vaccine Adjuvants Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Intramuscular Vaccine Adjuvants Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Intramuscular Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Intramuscular Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Intramuscular Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Intramuscular Vaccine Adjuvants Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Intramuscular Vaccine Adjuvants Production Market Share (2019-2024)
    Table 37. China Based Intramuscular Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Intramuscular Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Intramuscular Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Intramuscular Vaccine Adjuvants Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Intramuscular Vaccine Adjuvants Production Market Share (2019-2024)
    Table 42. Rest of World Based Intramuscular Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production Market Share (2019-2024)
    Table 47. World Intramuscular Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Intramuscular Vaccine Adjuvants Production by Type (2019-2024) & (K Units)
    Table 49. World Intramuscular Vaccine Adjuvants Production by Type (2025-2030) & (K Units)
    Table 50. World Intramuscular Vaccine Adjuvants Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Intramuscular Vaccine Adjuvants Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Intramuscular Vaccine Adjuvants Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Intramuscular Vaccine Adjuvants Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Intramuscular Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Intramuscular Vaccine Adjuvants Production by Application (2019-2024) & (K Units)
    Table 56. World Intramuscular Vaccine Adjuvants Production by Application (2025-2030) & (K Units)
    Table 57. World Intramuscular Vaccine Adjuvants Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Intramuscular Vaccine Adjuvants Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Intramuscular Vaccine Adjuvants Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Intramuscular Vaccine Adjuvants Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. GSK Basic Information, Manufacturing Base and Competitors
    Table 62. GSK Major Business
    Table 63. GSK Intramuscular Vaccine Adjuvants Product and Services
    Table 64. GSK Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. GSK Recent Developments/Updates
    Table 66. GSK Competitive Strengths & Weaknesses
    Table 67. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
    Table 68. Dynavax Technologies Major Business
    Table 69. Dynavax Technologies Intramuscular Vaccine Adjuvants Product and Services
    Table 70. Dynavax Technologies Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Dynavax Technologies Recent Developments/Updates
    Table 72. Dynavax Technologies Competitive Strengths & Weaknesses
    Table 73. Novavax Basic Information, Manufacturing Base and Competitors
    Table 74. Novavax Major Business
    Table 75. Novavax Intramuscular Vaccine Adjuvants Product and Services
    Table 76. Novavax Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Novavax Recent Developments/Updates
    Table 78. Novavax Competitive Strengths & Weaknesses
    Table 79. Agenus Basic Information, Manufacturing Base and Competitors
    Table 80. Agenus Major Business
    Table 81. Agenus Intramuscular Vaccine Adjuvants Product and Services
    Table 82. Agenus Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Agenus Recent Developments/Updates
    Table 84. Agenus Competitive Strengths & Weaknesses
    Table 85. Croda International Basic Information, Manufacturing Base and Competitors
    Table 86. Croda International Major Business
    Table 87. Croda International Intramuscular Vaccine Adjuvants Product and Services
    Table 88. Croda International Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Croda International Recent Developments/Updates
    Table 90. Croda International Competitive Strengths & Weaknesses
    Table 91. Seppic Basic Information, Manufacturing Base and Competitors
    Table 92. Seppic Major Business
    Table 93. Seppic Intramuscular Vaccine Adjuvants Product and Services
    Table 94. Seppic Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Seppic Recent Developments/Updates
    Table 96. Seppic Competitive Strengths & Weaknesses
    Table 97. OZ Biosciences Basic Information, Manufacturing Base and Competitors
    Table 98. OZ Biosciences Major Business
    Table 99. OZ Biosciences Intramuscular Vaccine Adjuvants Product and Services
    Table 100. OZ Biosciences Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. OZ Biosciences Recent Developments/Updates
    Table 102. OZ Biosciences Competitive Strengths & Weaknesses
    Table 103. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
    Table 104. Phibro Animal Health Major Business
    Table 105. Phibro Animal Health Intramuscular Vaccine Adjuvants Product and Services
    Table 106. Phibro Animal Health Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Phibro Animal Health Recent Developments/Updates
    Table 108. Phibro Animal Health Competitive Strengths & Weaknesses
    Table 109. Associated British Foods Basic Information, Manufacturing Base and Competitors
    Table 110. Associated British Foods Major Business
    Table 111. Associated British Foods Intramuscular Vaccine Adjuvants Product and Services
    Table 112. Associated British Foods Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Associated British Foods Recent Developments/Updates
    Table 114. Associated British Foods Competitive Strengths & Weaknesses
    Table 115. InvivoGen Basic Information, Manufacturing Base and Competitors
    Table 116. InvivoGen Major Business
    Table 117. InvivoGen Intramuscular Vaccine Adjuvants Product and Services
    Table 118. InvivoGen Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. InvivoGen Recent Developments/Updates
    Table 120. InvivoGen Competitive Strengths & Weaknesses
    Table 121. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 122. Merck KGaA Major Business
    Table 123. Merck KGaA Intramuscular Vaccine Adjuvants Product and Services
    Table 124. Merck KGaA Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Merck KGaA Recent Developments/Updates
    Table 126. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 127. CSL Limited Major Business
    Table 128. CSL Limited Intramuscular Vaccine Adjuvants Product and Services
    Table 129. CSL Limited Intramuscular Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 130. Global Key Players of Intramuscular Vaccine Adjuvants Upstream (Raw Materials)
    Table 131. Intramuscular Vaccine Adjuvants Typical Customers
    Table 132. Intramuscular Vaccine Adjuvants Typical Distributors
List of Figure
    Figure 1. Intramuscular Vaccine Adjuvants Picture
    Figure 2. World Intramuscular Vaccine Adjuvants Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Intramuscular Vaccine Adjuvants Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Intramuscular Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 5. World Intramuscular Vaccine Adjuvants Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Intramuscular Vaccine Adjuvants Production Value Market Share by Region (2019-2030)
    Figure 7. World Intramuscular Vaccine Adjuvants Production Market Share by Region (2019-2030)
    Figure 8. North America Intramuscular Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 9. Europe Intramuscular Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 10. China Intramuscular Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 11. Japan Intramuscular Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 12. Intramuscular Vaccine Adjuvants Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 15. World Intramuscular Vaccine Adjuvants Consumption Market Share by Region (2019-2030)
    Figure 16. United States Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 17. China Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 18. Europe Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 19. Japan Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 22. India Intramuscular Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Intramuscular Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Intramuscular Vaccine Adjuvants Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Intramuscular Vaccine Adjuvants Markets in 2023
    Figure 26. United States VS China: Intramuscular Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Intramuscular Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Intramuscular Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Intramuscular Vaccine Adjuvants Production Market Share 2023
    Figure 30. China Based Manufacturers Intramuscular Vaccine Adjuvants Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Intramuscular Vaccine Adjuvants Production Market Share 2023
    Figure 32. World Intramuscular Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Intramuscular Vaccine Adjuvants Production Value Market Share by Type in 2023
    Figure 34. Infectious Diseases
    Figure 35. Cancer
    Figure 36. Others
    Figure 37. World Intramuscular Vaccine Adjuvants Production Market Share by Type (2019-2030)
    Figure 38. World Intramuscular Vaccine Adjuvants Production Value Market Share by Type (2019-2030)
    Figure 39. World Intramuscular Vaccine Adjuvants Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Intramuscular Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Intramuscular Vaccine Adjuvants Production Value Market Share by Application in 2023
    Figure 42. Research Applications
    Figure 43. Commercial Applications
    Figure 44. World Intramuscular Vaccine Adjuvants Production Market Share by Application (2019-2030)
    Figure 45. World Intramuscular Vaccine Adjuvants Production Value Market Share by Application (2019-2030)
    Figure 46. World Intramuscular Vaccine Adjuvants Average Price by Application (2019-2030) & (US$/Unit)
    Figure 47. Intramuscular Vaccine Adjuvants Industry Chain
    Figure 48. Intramuscular Vaccine Adjuvants Procurement Model
    Figure 49. Intramuscular Vaccine Adjuvants Sales Model
    Figure 50. Intramuscular Vaccine Adjuvants Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Companies Mentioned

GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited